Cargando…

Hepatitis B virus reactivation and antiviral prophylaxis during lung cancer chemotherapy: A systematic review and meta-analysis

BACKGROUND: Antiviral drugs have been recommended as prophylaxis for the reactivation of hepatitis B virus (HBV) infection in cancer patients undergoing chemotherapy. However, screening and antiviral prophylaxis for lung cancer remain controversial because of insufficient evidence. PURPOSE: In this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yu-tuan, Li, Xin, Liu, Zi-li, Xu, Zhou, Dai, Wei, Zhang, Ke, Wu, Jiu-song, Arshad, Bilal, Wu, Kai-nan, Kong, Ling-quan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480953/ https://www.ncbi.nlm.nih.gov/pubmed/28640902 http://dx.doi.org/10.1371/journal.pone.0179680

Ejemplares similares

A Novel Antiviral Treatment of Hepatitis C Virus Reactivation in a Breast Cancer Patient Undergoing Chemotherapy
por: Wu, Yu-Tuan, et al.
Publicado: (2017)

Status of lipid and lipoprotein in female breast cancer patients at initial diagnosis and during chemotherapy
por: Li, Xin, et al.
Publicado: (2018)

Efficacy and cardiac safety of the concurrent use of trastuzumab and anthracycline-based neoadjuvant chemotherapy for HER2-positive breast cancer: a systematic review and meta-analysis
por: Wu, Yu-Tuan, et al.
Publicado: (2018)

Significantly higher pathologic complete response (pCR) after the concurrent use of trastuzumab and anthracycline-based neoadjuvant chemotherapy for HER2-positive breast cancer: Evidence from a meta-analysis of randomized controlled trials
por: Wu, Yu-tuan, et al.
Publicado: (2018)

Thyrotoxicosis Occurring in Secondary Hyperparathyroidism Patients Undergoing Dialysis after Total Parathyroidectomy with Autotransplantation
por: Xu, Zhou, et al.
Publicado: (2017)

Effect of neoadjuvant chemotherapy on the expression of hormone receptors and Ki67 in Chinese breast cancer patients: A retrospective study of 525 patients
por: Wu, Yu-tuan, et al.
Publicado: (2018)

Antiviral prophylaxis inhibits cytomegalovirus reactivation in critical illness
por: Cowley, NJ, et al.
Publicado: (2015)

Optimal timing of antiviral therapy for patients with malignant tumor who presented with hepatitis B reactivation during chemotherapy and/or immunosuppressive therapy
por: Zou, Xiaofang, et al.
Publicado: (2020)

Antiviral Immunity and Prophylaxis
Publicado: (2011)

Clinical study on the prevalence and comparative analysis of metabolic syndrome and its components among Chinese breast cancer women and control population
por: Wu, Yu-tuan, et al.
Publicado: (2018)

Expanding Antiviral Prophylaxis During Pregnancy to Prevent Perinatal Hepatitis B Virus Infection: A Cost-effectiveness Study
por: Du, Jiangyang, et al.
Publicado: (2020)

Maternal hepatitis B e antigen can be an indicator for antiviral prophylaxis of perinatal transmission of hepatitis B virus
por: Lu, Ying, et al.
Publicado: (2021)

Study on the status of thyroid function and thyroid nodules in chinese breast cancer patients
por: Shi, Yanling, et al.
Publicado: (2017)

Effects of Antiviral Therapy on HBV Reactivation and Survival in Hepatocellular Carcinoma Patients Undergoing Hepatic Artery Infusion Chemotherapy
por: Liu, Shousheng, et al.
Publicado: (2021)

Negative genic switch of HER-2 in the primary tumor instead of the synchronous metastatic nodal lesions after neoadjuvant chemotherapy in a patient with primary HER2-positive breast cancer
por: Chen, Hao-ran, et al.
Publicado: (2017)

Antiviral treatment for chronic hepatitis B: Safety, effectiveness, and prognosis
por: Wu, Ya-Li, et al.
Publicado: (2019)

Discontinuation of antiviral prophylaxis correlates with high prevalence of hepatitis B virus (HBV) reactivation in rheumatoid arthritis patients with HBV carrier state: a real-world clinical practice
por: Mo, Ying-Qian, et al.
Publicado: (2014)

Incidence of mother‐to‐child transmission of hepatitis B in relation to maternal peripartum antiviral prophylaxis: A systematic review and meta‐analysis
por: Yao, Naijuan, et al.
Publicado: (2022)

The association of hepatitis B virus screening and antiviral prophylaxis with adverse liver outcomes in Chinese cancer patients undergoing chemotherapy: A retrospective study
por: He, Lan-Ying, et al.
Publicado: (2020)

A Comparison of Entecavir and Lamivudine for the Prophylaxis of Hepatitis B Virus Reactivation in Solid Tumor Patients Undergoing Systemic Cytotoxic Chemotherapy
por: Chen, Wen-Chi, et al.
Publicado: (2015)

Hepatitis B virus reactivation in rheumatoid arthritis
por: Wu, Ya-Li, et al.
Publicado: (2022)

Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study
por: Innocenti, Idanna, et al.
Publicado: (2022)

Antiviral Therapy for AECHB and Severe Hepatitis B (Liver Failure)
por: Ning, Qin, et al.
Publicado: (2019)

Clinical study on the relationship between hepatitis B virus infection and risk of breast cancer: a large sized case-control and single center study in southwest of China
por: Lu, Lin-Jie, et al.
Publicado: (2017)

Prevalence of Hepatitis B Reactivation Among Chinese Individuals With Chronic Hepatitis C Treated With Pan-Oral Direct-Acting Antivirals
por: Lee, Shou-Wu, et al.
Publicado: (2018)

Prophylaxis of hepatitis B virus (HBV) infection reactivation – recommendations of the Working Group for prevention of HBV reactivation
por: Pawłowska, Małgorzata, et al.
Publicado: (2019)

Risk of hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis C
por: Aggeletopoulou, Ioanna, et al.
Publicado: (2017)

The Compliance of Doctors with Viral Hepatitis B Screening and Antiviral Prophylaxis in Cancer Patients Receiving Cytotoxic Chemotherapy Using a Hospital-Based Screening Reminder System
por: Sun, Wei-Chih, et al.
Publicado: (2015)

Antiviral Chemotherapy
por: Tamm, Igor
Publicado: (1956)

Antiviral Chemotherapy
por: Burrell, Christopher J., et al.
Publicado: (2017)

Antiviral Prophylaxis and Isolation for the Control of Pandemic Influenza
por: Zhang, Qingxia, et al.
Publicado: (2014)

Antiviral Chemotherapyand Prophylaxis of Viral Respiratory Disease
por: Sperber, Steven J., et al.
Publicado: (1987)

Screening and prevention of hepatitis C virus reactivation during chemotherapy
por: Li, Yuan-Rung, et al.
Publicado: (2021)

P1507: A PREDICTIVE MODEL OF HERPES ZOSTER AFTER ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION: VZV REACTIVATION AFTER ANTIVIRAL PROPHYLAXIS DISCONTINUATION
por: Feng, Cheng-Jie, et al.
Publicado: (2023)

Cost-effectiveness of antiviral prophylaxis during pregnancy for the prevention of perinatal hepatitis B infection in South Korea
por: Lee, Donghoon, et al.
Publicado: (2018)

Reactivation of herpesvirus in patients with hepatitis C treated with direct-acting antiviral agents
por: Ghweil, Ali A, et al.
Publicado: (2019)

The interferon system as a basis for antiviral therapy or prophylaxis
por: Billiau, A.
Publicado: (1985)

The Future of Antiviral Chemotherapy
por: Crowe, Suzanne, et al.
Publicado: (1988)

Hepatitis B sero-prevalence among hematology patients: importance of Anti-HbcAb and efficiency of antiviral prophylaxis
por: Kantar, Funda Ugur, et al.
Publicado: (2022)

The prevalence and clinicopathological features of breast cancer patients with hepatitis B virus infection in China
por: Wu, He, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qavvttkmoqkmmhns16ae0tc6ok